Publicité
Publicité
APVO
Aptevo Therapeutics Inc
9.68
USDSponsorisé
+0.48
+5.18%
09 janv., 15:59 UTC -5
Fermé
Après-marché
9.10
-0.57
-5.92%
APVO Rapports sur les bénéfices
Ratio de surprise positive
APVO a dépassé 22 des 36 dernières estimations.
61%
Prochain rapport
Date du prochain rapport
12 févr. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.45
Variation implicite de Q3 25 (Revenue/ EPS)
--
/-75.81%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/-99.97%
Aptevo Therapeutics Inc earnings per share and revenue
On 06 nov. 2025, APVO reported earnings of -1.86 USD per share (EPS) for Q3 25, beating the estimate of -2.13 USD, resulting in a 12.75% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analystes forecast an EPS of -0.45 USD, with revenue projected to reach -- USD, implying an baisse of -75.81% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
What were Aptevo Therapeutics Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Aptevo Therapeutics Inc reported EPS of -$1.86, beating estimates by 12.75%, and revenue of $0.00, -- -- expectations.
How did the market react to Aptevo Therapeutics Inc's Q3 2025 earnings?
The stock price moved -- 0%, changed from $26.46 before the earnings release to $26.46 the day after.
When is Aptevo Therapeutics Inc expected to report next?
The next earning report is scheduled for 12 févr. 2026.
What are the forecasts for Aptevo Therapeutics Inc's next earnings report?
Based on 3
analystes, Aptevo Therapeutics Inc is expected to report EPS of -$0.45 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité